Read More

Asahi Kasei Makes $1.1B Offer For Swedish Drugmaker Calliditas Therapeutics, Enhancing Pharma Growth Strategy

Asahi Kasei's $1.1 billion acquisition of Calliditas Therapeutics offers 208 SEK per share in cash. The deal boosts Asahi Kasei's global presence in immunology and renal disease markets, aligning with its strategic growth and expansion in the U.S. and Europe.

CALT

Read More

What’s Going On With Energy Transfer Stock Tuesday?

Energy Transfer said it entered into a definitive agreement to acquire WTG Midstream from affiliates of Stonepeak, Davis Estate and Diamondback Energy. The transaction, which is valued at $3.25 billion, will include $2.45 billion in cash and about 50.8 million newly issued common units from Energy Transfer.

ET